Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC1R | Q01726 | 9/20 | 0.74 |
| ▸ | MC4R | P32245 | 9/20 | 0.74 |
| ▸ | MC5R | P33032 | 1/20 | 0.33 |
| ▸ | MC3R | P41968 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.31 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1311438 | 0.85 | MC4R (1.00) | MC1RMC4RMC5RMC3RPTPN1 | |
| SCHEMBL20450373 | 0.85 | MC4R (1.00) | MC1RMC4RMC5RMC3RPTPN1 | |
| SCHEMBL16188227 | 0.82 | MC1R (0.72) | MC1RMC4RMC5RMC3RMMP1 | |
| SCHEMBL16444996 | 0.80 | MC1R (0.70) | MC1RMC4RMC5RMC3RKMT2A | |
| SCHEMBL14360403 | 0.80 | MC4R (0.71) | MC1RMC4RMC5RMC3RKMT2A | |
| SCHEMBL1310203 | 0.78 | MC1R (0.65) | MC1RMC4RMC5RMC3RMMP1 | |
| SCHEMBL20450424 | 0.78 | MC1R (0.65) | MC1RMC4RMC5RMC3RMMP1 | |
| SCHEMBL1310622 | 0.78 | MC1R (0.65) | MC1RMC4RMC5RMC3RMMP1 | |
| SCHEMBL1325753 | 0.78 | MC1R (0.64) | MC1RMC4RMC5RMC3RMMP1 | |
| SCHEMBL2154629 | 0.78 | MC1R (0.83) | MC1RMC4RMC5RMC3RPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102203081-A | Oxoazetidine derivatives, method for the production thereof and use thereof in human medicine and cosmetics | GALDERMA RES & DEV | 2011-09-28 | — | — | CN | claimed |
| CN-102203081-A | Oxoazetidine derivatives, method for the production thereof and use thereof in human medicine and cosmetics | GALDERMA RES & DEV | 2011-09-28 | — | — | CN | disclosed |